Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 10 | Longs Won 4/9 44% | Profit Factor 0.27 |
| Profitability | Shorts Won 0/1 0% | Standard Deviation $5,635.48 |
| Average Win $1,846.13 | Best Trade (Sep 10) $6,203.2 | Sharpe Ratio -68.6 |
| Average Loss -$4,585.33 | Worst Trade (Jun 25) -$13,408.54 | Z-Score -0.91 (63.89%) |
| Commissions $0 | Avg. Trade Length 1m 3w 5d | Expectancy -$1,904.66 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 18 | 16 | 14 | 12 | 11 | 9 | 7 | 5 | 4 | 2 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
BIIB Biogen Inc. | -422.24 | $90,963.54 | $100,973.63 | - | -$10,010.09 | -11% | +2.709% |